• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder.

作者信息

Shapira N A, Keck P E, Goldsmith T D, McConville B J, Eis M, McElroy S L

机构信息

Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267-0559, USA.

出版信息

Depress Anxiety. 1997;6(4):170-3.

PMID:9559288
Abstract
摘要

相似文献

1
Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder.盐酸曲马多治疗难治性强迫症的开放标签试验性研究。
Depress Anxiety. 1997;6(4):170-3.
2
Potential for Drug-Drug Interactions with Adjunctive Tramadol Use in Treatment of Obsessive-Compulsive Disorder.在强迫症治疗中联合使用曲马多存在药物相互作用的可能性。
Can J Psychiatry. 2016 May;61(5):308-9. doi: 10.1177/0706743716633423.
3
Rapid remission of OCD with tramadol hydrochloride.盐酸曲马多使强迫症快速缓解。
Am J Psychiatry. 1999 Apr;156(4):660-1. doi: 10.1176/ajp.156.4.660a.
4
Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
CNS Spectr. 2007 Jul;12(7):519-24. doi: 10.1017/s1092852900021258.
5
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.在对选择性5-羟色胺再摄取抑制剂难治的强迫症中加用奥氮平：一项开放标签病例系列研究
J Clin Psychiatry. 1999 Aug;60(8):524-7. doi: 10.4088/jcp.v60n0804.
6
Possible interaction of tramadol and antidepressants.曲马多与抗抑郁药之间可能存在的相互作用。
Am J Psychiatry. 2000 May;157(5):839. doi: 10.1176/appi.ajp.157.5.839.
7
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder.帕利哌酮增效治疗五羟色胺再摄取抑制剂抵抗性强迫症的双盲、安慰剂对照、初步试验。
J Clin Psychiatry. 2013 Jun;74(6):e527-32. doi: 10.4088/JCP.12m08278.
8
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.阿立哌唑增强5-羟色胺再摄取抑制剂治疗难治性强迫症：一项为期12周的开放标签初步研究。
Int Clin Psychopharmacol. 2009 Sep;24(5):265-9. doi: 10.1097/YIC.0b013e32832e9b91.
9
Similar effects of tramadol and venlafaxine in major depressive disorder.曲马多和文拉法辛在重度抑郁症中的相似作用。
South Med J. 2008 Feb;101(2):193-5. doi: 10.1097/SMJ.0b013e3181616e66.
10
Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.选择性 5-羟色胺再摄取抑制剂对强迫症中思维-行动融合、元认知和思维抑制的影响。
Compr Psychiatry. 2011 Sep-Oct;52(5):556-61. doi: 10.1016/j.comppsych.2010.10.003. Epub 2010 Dec 15.

引用本文的文献

1
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors.EPD1504：一种新型μ-阿片受体部分激动剂可减轻强迫症（OCD）样行为。
Front Psychiatry. 2023 Jun 30;14:1170541. doi: 10.3389/fpsyt.2023.1170541. eCollection 2023.
2
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.成人强迫症药物治疗的专业知识和能力标准。
Psychiatry Res. 2021 Jun;300:113853. doi: 10.1016/j.psychres.2021.113853. Epub 2021 Mar 4.
3
Opioidergic Agents as Antidepressants: Rationale and Promise.
阿片类药物作为抗抑郁药：原理与前景。
CNS Drugs. 2019 Jan;33(1):9-16. doi: 10.1007/s40263-018-0584-7.
4
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).精神药理学治疗强迫症（OCD）。
Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017.
5
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.抑郁症中内源性阿片系统失调：对新治疗方法的启示。
Mol Psychiatry. 2019 Apr;24(4):576-587. doi: 10.1038/s41380-018-0117-2. Epub 2018 Jun 28.
6
Potential for Drug-Drug Interactions with Adjunctive Tramadol Use in Treatment of Obsessive-Compulsive Disorder.在强迫症治疗中联合使用曲马多存在药物相互作用的可能性。
Can J Psychiatry. 2016 May;61(5):308-9. doi: 10.1177/0706743716633423.
7
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.合成与受体信号探索：美沙酮生物碱作为阿片受体调节剂的非典型分子骨架。
J Am Chem Soc. 2016 Jun 1;138(21):6754-64. doi: 10.1021/jacs.6b00360. Epub 2016 May 18.
8
Pharmacological treatment of obsessive-compulsive disorder.强迫症的药物治疗
Psychiatr Clin North Am. 2014 Sep;37(3):375-91. doi: 10.1016/j.psc.2014.05.006. Epub 2014 Jul 24.
9
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.加拿大焦虑、创伤后应激障碍和强迫症管理临床实践指南。
BMC Psychiatry. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2.
10
Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder.丁丙诺啡增效治疗难治性强迫症。
Ther Adv Psychopharmacol. 2013 Feb;3(1):15-9. doi: 10.1177/2045125312462233.